Company / Depreciation & Amortization
NOVAVAX INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$28.0M
FY2025
5-year range
$4.3M / $48.0M
FY2021-FY2025
Trend
-41.7%
vs FY2024
Sector context
#39 of 163
Health Care
What the data says
NOVAVAX INC's depreciation & amortization of $28M is higher than 76% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $4M in FY2022 to $48M in FY2024.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +45.5%. Top quartile in the Health Care sector.
Improved from $41M to $28M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +86.7%
- 5-Year CAGR
- +45.5%
- 10-Year CAGR
- -
Sector benchmark
-87.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +45.5%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 41.7% year-over-year.
- Ranks #39 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.0M | -41.7% |
| FY2024 | $48.0M | +17.1% |
| FY2023 | $41.0M | +853.5% |
| FY2022 | $4.3M | -66.9% |
| FY2021 | $13.0M | +202.3% |
| FY2020 | $4.3M | -43.4% |
| FY2019 | $7.6M | -1.3% |
| FY2018 | $7.7M | +51.0% |
| FY2017 | $5.1M | +15.9% |
| FY2016 | $4.4M | +69.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026